Market Tracker

04/24 3:31pm ET
13.77
Real-Time Quote
 -0.13 / -0.94%
Today’s Change
11.78
Today|||52-Week Range
20.25
-6.13%
Year-to-Date

Today’s Trading

Previous close13.90
Today’s open13.96
Day’s range13.25 - 14.17
Volume611,857
Average volume (3 months)883,534
Market cap$1.2B
Dividend yield--
Data as of 3:16pm ET, 04/24/2014

Growth & Valuation

Earnings growth (last year)+8.42%
Earnings growth (this year)+17.15%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+117.25%
P/E ratioNM
Price/Sales39.25
Price/Book9.49

Competitors

 Today’s
change
Today’s
% change
AEGRAegerion Pharmaceuti...+1.38+3.14%
OPHTOphthotech Corp-0.37-1.05%
HALOHalozyme Therapeutic...-0.09-1.19%
NVAXNovavax Inc-0.08-1.80%
Data as of 3:31pm ET, 04/24/2014

Financials

Next reporting dateApril 25, 2014
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$35.5M
Annual profit (last year)-$72.8M
Net profit margin-204.90%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts